Since we found that SALL2 was overexpressed in T-ALL-derived cells and because, during normal hematopoiesis, its expression is limited to HSCs, we believe that the expression of this gene could be useful as a lineage marker and as a potential therapeutic target. The gene discussed is SALL2; the disease is acute lymphoblastic leukemia.